CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout
← All indications

Bone Resorption

Bone loss due to osteoclastic activity.

Subtype terms (4)

More specific conditions that are subtypes of Bone Resorption in the MeSH hierarchy.

  • Ainhum
  • Alveolar Bone Loss

    66 drugs (35 approved, 31 experimental)

  • Atrophic Maxilla
  • Osteolysis

    3 drugs (2 approved, 1 experimental)

Drugs by status

Phase 4 trials (2)

  • denosumab
  • alendronic acid

Phase 3 trials (4)

  • platelet rich fibrin
  • dentin
  • collagen
  • zoledronic acid

Phase 2 trials (1)

  • whey protein

Phase 1 trials (4)

  • ibuprofen
  • platelet-rich plasma
  • celecoxib
  • flurbiprofen

Other trials (2)

  • calcium carbonate
  • tonzonium

Organizations

Organization Involved with Phase 4 Indications (5)

  • AbbVie
  • Harvard University
  • Federal University of Minas Gerais
  • University of Barcelona
  • University of Sherbrooke

Organization Involved with Phase 3 Indications (4)

  • Novartis
  • Dr. D. Y. Patil Dental College & Hospital
  • Columbia University
  • Santosh University

Organization Involved with Phase 2 Indications (8)

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • Azad University
  • Stanford University
  • University of Kentucky
  • University of Nebraska
  • Yale University
  • Department of Defense
  • Office of Dietary Supplements (ODS)

Organization Involved with Other Experimental Indications (12)

  • Abbott
  • Dentsply International
  • National Institute of Environmental Health Sciences (NIEHS)
  • Brock University
  • Cairo University
  • Meenakshi Ammal Dental College and Hospital
  • Peking University
  • Purdue University
  • University of California, Berkeley
  • Government of Mexico
  • Tate & Lyle
  • VRR diagnostic institute chennai

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.